Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients
Clinical trial NCT03812549 · COMPLETED
Trial details
- NCT number
- NCT03812549
- Sponsor
- Sichuan University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-18
- Primary completion
- 2022-01-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.